Provided by Tiger Trade Technology Pte. Ltd.

Myers

32.09
-0.7100-2.16%
Pre-market: 32.08-0.0100-0.03%08:37 EDT
Volume:702.04K
Turnover:22.50M
Market Cap:1.21B
PE:33.16
High:32.97
Open:32.69
Low:31.59
Close:32.80
52wk High:37.45
52wk Low:15.54
Shares:37.62M
Float Shares:36.71M
Volume Ratio:2.49
T/O Rate:1.91%
Dividend:0.54
Dividend Rate:1.68%
EPS(TTM):0.9677
EPS(LYR):0.9300
ROE:17.15%
ROA:7.63%
PB:3.94
PE(LYR):34.51

Loading ...

Myers Industries Divests Myers Tire Supply Business

TIPRANKS
·
16 hours ago

Myers Industries Completes Sale of Myers Tire Supply

THOMSON REUTERS
·
16 hours ago

Myers Industries management to meet virtually with KeyBanc

TIPRANKS
·
17 hours ago

Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study

TIPRANKS
·
Yesterday

Mastermyne Group (ASX:MYE) Shares Reflect Margin Gains But Legal Risks Linger

Simply Wall St.
·
Aug 26

Carrier Stock And 2 US Industrial Picks For Canada Tariff Substitution

Simply Wall St.
·
Aug 24

Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports

TIPRANKS
·
Aug 12

C29 Metals Director James Myers Increases Shareholding via On‑Market Purchase

TIPRANKS
·
Aug 10

No $400B Mega Merger? AstraZeneca Rises, Bristol Myers Falls as Report Denies Deal

TIPRANKS
·
Aug 05

Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls

TIPRANKS
·
Aug 05

Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports

TIPRANKS
·
Aug 05

Market Chatter: AstraZeneca, Bristol Myers Not Pursuing Merger Talks

MT Newswires Live
·
Aug 05

AstraZeneca deal talks with Bristol Myers remain active, Semafor says

TIPRANKS
·
Aug 05

TD Cowen sees no strategic logic in an AstraZeneca-Bristol Myers merger

TIPRANKS
·
Aug 04

AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus

Benzinga
·
Aug 04

European Stocks Close Mostly Higher in Monday Trading; AstraZeneca Reportedly in Merger Talks With Bristol Myers

MT Newswires Live
·
Aug 03

Citi views report of AstraZeneca, Bristol Myers talks as surprising

TIPRANKS
·
Aug 03

Bristol Myers price target raised to $70 from $66 at Citi

TIPRANKS
·
Aug 03

Why Myers Industries (MYE) Is Up 8.7% After Strong Q2 Profitability And Expanded Credit Facilities – And What's Next

Simply Wall St.
·
Aug 03

AstraZeneca in discussions to combine with Bristol Myers for $400B, FT says

TIPRANKS
·
Aug 03